🔎 Trials Near Me

Почетна › Srpastoćelijska bolest › Њујорк

Kliničke studije za Srpastoćelijska bolest u državi Њујорк

23 studija za Srpastoćelijska bolest traži učesnike na lokacijama u državi Њујорк.

Gradovi u državi Њујорк

Zvanični tekst studije (na engleskom)

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • Mount Sinai Hospital, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07187973

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Childrens Hospital at Montefiore, The Bronx
Тражи се учесникФаза 3
Узраст од 12 до 100 · Оба пола · Ажурирано 10. 11. 2026. · NCT06439082

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • NYC Health + Hospitals/Queens, Jamaica
  • Columbia University Medical Center, New York
  • Jacobi Medical Center, The Bronx
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07224360

A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

  • Icahn School of Medicine at Mount Sinai, New York
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07656415

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  • Icahn School Of Med At Mount Sinai, New York
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст од 12 до 55 · Оба пола · Ажурирано 27. 10. 2026. · NCT06546670

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

  • New York Medical College, Valhalla
Тражи се учесникФаза 2
1 Day – 30 Years · Оба пола · Ажурирано 23. 10. 2026. · NCT04099966

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • Richmond University Medical Center- Site Number : 8400038, Staten Island
  • Montefiore Medical Center - Moses Campus- Site Number : 8400057, The Bronx
Тражи се учесникФаза 3
Узраст од 10 до 65 · Оба пола · Ажурирано 15. 10. 2026. · NCT06975865

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • Weil Cornell Medical College, New York
  • University of Rochester Medical Center, Rochester
Тражи се учесник
Узраст од 16 до 39 · Оба пола · Ажурирано 8. 10. 2026. · NCT06374238

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • Mount Sinai Medical Center, New York
  • Jacobi Medical Center, The Bronx
Тражи се учесникФаза 2
Узраст 12 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT06699849

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  • Columbia University Medical Center_New York_0, New York
  • Columbia University Medical Center_New York_0, New York
Тражи се учесникФаза 3
Узраст 2 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • NYC Health+Hospitals, Brooklyn
  • Interfaith Medical Center, Brooklyn
  • Cohen Children's Medical Ctr, Queens
  • и још 2
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 17. 9. 2026. · NCT06612268

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • Icahn School of Medicine at Mount Sinai, New York
  • Jacobi Medical Center, The Bronx
Тражи се учесникФаза 2/3
Узраст 12 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Western New York BloodCare, Buffalo
  • Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
  • Weill Cornell Medical College - New York Presbyterian Hospital, New York
  • и још 2
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 17. 8. 2026. · NCT04398628

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

  • New York Medical College, Valhalla
Тражи се учесникФаза 2
6 Months – 21 Years · Оба пола · Ажурирано 27. 7. 2026. · NCT02675959

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering, New York
Тражи се учесникФаза 1/2
Узраст од 12 до 50 · Оба пола · Ажурирано 2. 7. 2026. · NCT04819841

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

  • Columbia University Irving Medical Center, New York
Тражи се учесникФаза 1
Узраст од 12 до 50 · Оба пола · Ажурирано 10. 6. 2026. · NCT07015684

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Roswell Park (MRD-HCT), Buffalo
  • Columbia Presbytarian (NT-DMT), New York
  • Cohen's Children Hospital (NT-DMT), Queens
  • и још 4
Тражи се учесникОпсервациона студија
Узраст од 3 до 20 · Оба пола · Ажурирано 4. 6. 2026. · NCT06941389

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

  • Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
  • Memorial Sloan Kettering Westchester (Consent only), Harrison
  • Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
Тражи се учесникФаза 2
Узраст од 2 до 50 · Оба пола · Ажурирано 3. 6. 2026. · NCT05736419

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

  • New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Тражи се учесникФаза 3
Узраст од 12 до 35 · Оба пола · Ажурирано 23. 3. 2026. · NCT05477563

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

  • Columbia University, New York
Тражи се учесникФаза 2
Узраст од 2 до 25 · Оба пола · Ажурирано 10. 3. 2026. · NCT03587272

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • Columbia University Irving Medical Center, New York
Тражи се учесникОпсервациона студија
Узраст од 14 до 37 · Оба пола · Ажурирано 28. 1. 2026. · NCT07373639

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

  • Mount Sinai Hospital, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2025. · NCT05519111

Cannabidiol in Sickle Cell Disease

  • Icahn School of Medicine at Mount Sinai, Manhattan
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 25. 6. 2025. · NCT06930703

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.